Table 2.
Fibrosis staging of non-tumor liver parenchyma from both Peruvian patients with hepatocellular carcinoma and comparative individuals.
| Fibrosis stage | Contingency in Patient Group (n) | Percentage in Patient Group (%) | Contingency in Comparative Group (n) | Percentage in Comparative Group (%) |
|---|---|---|---|---|
| Stage 0 | 17 | 34 | 33 | 44 |
| Stage 1 | 14 | 28 | 21 | 28 |
| Stage 2 | 5 | 10 | 11 | 14.6 |
| Stage 3 | 6 | 12 | 6 | 8 |
| Stage 4 | 8 | 16 | 4 | 5.4 |
| Total | 50 | 100 | 75 | 100 |
Scheuer staging system was used to determine the stage of hepatic fibrosis54. Stage 0, no fibrosis and normal amount of connective tissue; Stage 1, enlarged, fibrotic portal tracts; Stage 2, periportal or portal-portal septa, but intact architecture; Stage 3, bridging fibrosis with architectural distortion, but no obvious cirrhosis; Stage 4, probable or definite cirrhosis.